Essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development

GTF2I and GTF2IRD1 encoding the multifunctional transcription factors TFII-I and BEN are clustered at the 7q11.23 region hemizygously deleted in Williams-Beuren syndrome (WBS), a complex multisystemic neurodevelopmental disorder. Although the biochemical properties of TFII-I family transcription factors have been studied in depth, little is known about the specialized contributions of these factors in pathways required for proper embryonic development. Here, we show that homozygous loss of either Gtf2ird1 or Gtf2i function results in multiple phenotypic manifestations, including embryonic lethality; brain hemorrhage; and vasculogenic, craniofacial, and neural tube defects in mice. Further analyses suggest that embryonic lethality may be attributable to defects in yolk sac vasculogenesis and angiogenesis. Microarray data indicate that the Gtf2ird1 homozygous phenotype is mainly caused by an impairment of the genes involved in the TGFβRII/Alk1/Smad5 signal transduction pathway. The effect of Gtf2i inactivation on this pathway is less prominent, but downregulation of the endothelial growth factor receptor-2 gene, resulting in the deterioration of vascular signaling, most likely exacerbates the severity of the Gtf2i mutant phenotype. A subset of Gtf2ird1 and Gtf2i heterozygotes displayed microcephaly, retarded growth, and skeletal and craniofacial defects, therefore showing that haploinsufficiency of TFII-I proteins causes various developmental anomalies that are often associated with WBS.

[1]  P. Fletcher,et al.  Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1‐targeted mice , 2008, Genes, brain, and behavior.

[2]  A. Roy Signal-induced functions of the transcription factor TFII-I. , 2007, Biochimica et biophysica acta.

[3]  F. Ruddle,et al.  Expression profiling of BEN regulated genes in mouse embryonic fibroblasts. , 2007, Journal of experimental zoology. Part B, Molecular and developmental evolution.

[4]  F. Ruddle,et al.  Gene expression analysis of TFII-I modulated genes in mouse embryonic fibroblasts. , 2007, Journal of experimental zoology. Part B, Molecular and developmental evolution.

[5]  A. Roy,et al.  Cutting Edge: TFII-I Controls B Cell Proliferation via Regulating NF-κB1 , 2007, The Journal of Immunology.

[6]  Stephen J. Palmer,et al.  Expression of Gtf2ird1, the Williams syndrome-associated gene, during mouse development. , 2007, Gene expression patterns : GEP.

[7]  P. Sharp,et al.  Opposing functions of TFII-I spliced isoforms in growth factor-induced gene expression. , 2006, Molecular cell.

[8]  S. Snyder,et al.  Action of TFII-I Outside the Nucleus as an Inhibitor of Agonist-Induced Calcium Entry , 2006, Science.

[9]  M. Quigley,et al.  Thoracolumbar Syrinx in Association With Williams Syndrome , 2006, Pediatrics.

[10]  Joan Murphy,et al.  Comparison of Respiratory Physiologic Features When Infants Are Placed in Car Safety Seats or Car Beds , 2006, Pediatrics.

[11]  Joaquín Dopazo,et al.  BABELOMICS: a systems biology perspective in the functional annotation of genome-scale experiments , 2006, Nucleic Acids Res..

[12]  Robert H. Shoemaker,et al.  Complex interactions of HIV-1 nucleocapsid protein with oligonucleotides , 2006, Nucleic Acids Research.

[13]  Peter Hammond,et al.  GTF2IRD1 in Craniofacial Development of Humans and Mice , 2005, Science.

[14]  A. Buonanno,et al.  Multiple GTF2I-like Repeats of General Transcription Factor 3 Exhibit DNA Binding Properties , 2005, Journal of Biological Chemistry.

[15]  S. Desiderio,et al.  Vascular Endothelial Growth Factor Receptor-2 , 2005, Journal of Biological Chemistry.

[16]  May Tassabehji,et al.  Comparison of TFII‐I gene family members deleted in Williams‐Beuren syndrome , 2004, Protein science : a publication of the Protein Society.

[17]  F. Ruddle,et al.  GTF2IRD2 is located in the Williams-Beuren syndrome critical region 7q11.23 and encodes a protein with two TFII-I-like helix-loop-helix repeats. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  F. Ruddle,et al.  Expression of BEN, a member of TFII-I family of transcription factors, during mouse pre- and postimplantation development. , 2003, Gene expression patterns : GEP.

[19]  A. Buonanno,et al.  Characterization of General Transcription Factor 3, a Transcription Factor Involved in Slow Muscle-specific Gene Expression* , 2003, The Journal of Biological Chemistry.

[20]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[21]  M. Goumans,et al.  Abnormal angiogenesis but intact hematopoietic potential in TGF‐β type I receptor‐deficient mice , 2001, The EMBO journal.

[22]  J. Ihle The Challenges of Translating Knockout Phenotypes into Gene Function , 2000, Cell.

[23]  F. Ruddle,et al.  Isolation and characterization of BEN, a member of the TFII-I family of DNA-binding proteins containing distinct helix-loop-helix domains. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Goumans,et al.  Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. , 2000, The International journal of developmental biology.

[25]  P. Donahoe,et al.  Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Carmeliet,et al.  Transgenic mouse models in angiogenesis and cardiovascular disease , 2000, The Journal of pathology.

[27]  M. Goumans,et al.  Transforming growth factor-beta signalling in extraembryonic mesoderm is required for yolk sac vasculogenesis in mice. , 1999, Development.

[28]  Ursula Bellugi,et al.  Bridging cognition, the brain and molecular genetics: evidence from Williams syndrome , 1999, Trends in Neurosciences.

[29]  C. Deng,et al.  Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. , 1999, Development.

[30]  C. Patterson,et al.  The Human KDR/flk-1 Gene Contains a Functional Initiator Element That Is Bound and Transactivated by TFII-I* , 1999, The Journal of Biological Chemistry.

[31]  M. Taketo,et al.  TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. , 1996, Developmental biology.

[32]  Janet Rossant,et al.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.

[33]  H. King,et al.  Kyphoscoliosis in Williams syndrome. , 1994, Spine.

[34]  A. Roy,et al.  Cutting Edge: TFII-I controls B cell proliferation via regulating NF-kappaB. , 2007, Journal of immunology.

[35]  F. Ruddle,et al.  The early embryonic expression of TFII-I during mouse preimplantation development. , 2004, Gene expression patterns : GEP.

[36]  F. Ruddle,et al.  Genomic organization of the genes Gtf2ird1, Gtf2i, and Ncf1 at the mouse chromosome 5 region syntenic to the human chromosome 7q11.23 Williams syndrome critical region. , 2002, Genomics.

[37]  C A Morris,et al.  Williams syndrome and related disorders. , 2000, Annual review of genomics and human genetics.